Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG and CSA vs Supportive Care in MDS
NCT00004208Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Aug 2000
- Primary completion
- Oct 2006
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin, cyclosporine in myelodysplastic syndrome (MDS), sponsored by Swiss Group for Clinical Cancer Research. Started Aug 2000; status: completed.
02
Drugs
antithymocyte globulincyclosporine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00004208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004208.